Overview
Gerald Gehr is an Oncologist in Manchester, New Hampshire. Dr. Gehr is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Thrombocytopenia, Angiosarcoma, Paget Disease of the Breast, and Cutaneous T-Cell Lymphoma (CTCL).
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The General Hospital Corporation
Keith Flaherty is an Oncologist in Boston, Massachusetts. Dr. Flaherty is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Melanoma of the Eye, Tissue Biopsy, and Nephrectomy. Dr. Flaherty is currently accepting new patients.
The General Hospital Corporation
Donald Lawrence is an Oncologist and a Hematologist in Waltham, Massachusetts. Dr. Lawrence is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Melanoma of the Eye, and Liver Embolization. Dr. Lawrence is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Patrick Ott is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Ott is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Gastroesophageal Junction Cancer, Small Cell Lung Cancer (SCLC), Metastatic Uveal Melanoma, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ThrombocytopeniaDr. Gehr isDistinguished. Learn about Thrombocytopenia.
- Advanced
- AngiosarcomaDr. Gehr isAdvanced. Learn about Angiosarcoma.
- Cutaneous T-Cell Lymphoma (CTCL)
- Paget Disease of the BreastDr. Gehr isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Gehr isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Soft Tissue SarcomaDr. Gehr isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Gehr isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Gehr isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Arteriovenous MalformationDr. Gehr isExperienced. Learn about Arteriovenous Malformation.